India-Based Knee Osteoarthritis Evaluation (iKare): A Multi-Centre Cross-Sectional Study on the Management of Knee Pain and Early Osteoarthritis in India.
10.4055/cios.2017.9.3.286
- Author:
Parag SANCHETI
1
;
Vijay D SHETTY
;
Mandeep S DHILLON
;
Sheila A SPRAGUE
;
Mohit BHANDARI
Author Information
1. Sancheti Institute for Orthopedics and Rehabilitation, Pune, India.
- Publication Type:Original Article
- Keywords:
Osteoarthritis;
Knee;
India;
Cross-sectional studies
- MeSH:
Congenital Abnormalities;
Cross-Sectional Studies*;
Demography;
Hospitals, Private;
Humans;
India*;
Informed Consent;
Injections, Intra-Articular;
Knee*;
Logistic Models;
Methods;
North America;
Osteoarthritis*;
Osteoarthritis, Knee*;
Prescriptions;
Social Class;
Specialization;
Surgeons;
Surveys and Questionnaires
- From:Clinics in Orthopedic Surgery
2017;9(3):286-294
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Access to early knee osteoarthritis treatment in low and middle income nations is often believed to be limited. We conducted a cross-sectional study in India to assess prior access to treatment among patients presenting with knee pain to specialist orthopaedic clinics. METHODS: The multi-centre, cross-sectional study included patients presenting with knee pain at 3 hospitals in India. Patients who met the inclusion criteria and provided informed consent completed a questionnaire designed to assess patient demographics, socioeconomic status, knee pain, treatment method, and patient's knowledge on osteoarthritis (OA). Their orthopaedic surgeons also completed a questionnaire on the severity of patient's OA and their recommended treatments. The impact of demographic characteristics on the prescription of treatment options was analyzed using logistic regression. RESULTS: A total of 714 patients met the eligibility criteria and participated in this study. The majority of patients had been experiencing pain for less than 1 year (64.8%) and had previously been prescribed medications (91.6%), supplements (68.6%), and nonpharmacological (81.9%) treatments to manage their knee OA. Current treatment recommendations included oral medications (83.3%), intra-articular injections (29.8%), and surgical intervention (12.7%). Prescription of oral medications was related to younger age, lack of deformities, and lower Kellgren-Lawrence grades (p < 0.01). Patients treated in private hospital settings were more likely to have been previously treated with medications (range, 84.3% to 92.6%; p < 0.01) and physical treatments (range, 61.8% to 84.8%; p < 0.01) than patients treated at government hospitals. CONCLUSIONS: Contrary to the perception, our findings suggest a similar proportion of early knee OA treatment between India and North America.
